SENATE
HOUSE
JOINT
BILL STATUS
STATE LAW
REPORTS
EDUCATIONAL
CONTACT
home
home
Introduced Version House Bill 4270 History

   |  Email
Key: Green = existing Code. Red = new code to be enacted
206 CSR 1
H. B. 4270


(By Delegates Brown, Miley, Burdiss, Talbott

and Sobonya)

[Introduced January 25, 2008; referred to the Committee on

Health and Human Resources then the Judiciary.]




A BILL to amend and reenact article 9, chapter 64 of the Code of West Virginia, 1931, as amended, relating to authorizing the Office of the Pharmaceutical Advocate to promulgate a legislative rule relating to prescription drug advertising expense reporting.

Be it enacted by the Legislature of West Virginia:
That article 9, chapter 64 of the Code of West Virginia, 1931, as amended, be amended and reenacted to read as follows:
ARTICLE 9. AUTHORIZATION FOR MISCELLANEOUS AGENCIES AND BOARDS TO PROMULGATE LEGISLATIVE RULES.

§64-9-1. Office of the Pharmaceutical Advocate.
The legislative rule filed in the state register on the ninth day of July, two thousand seven, authorized under the authority of section thirteen, article three-c, chapter five-a, of this code, modified by the Office of the Pharmaceutical Advocate to meet the objections of the legislative rule-making review committee and refiled in the state register on the fourteenth day of January, two thousand eight, relating to the Office of the Pharmaceutical Advocate (prescription drug advertising expense reporting, 206 CSR 1), is authorized.

NOTE: The purpose of this bill is to authorize the Office of the Pharmaceutical Advocate to promulgate a legislative rule relating to Prescription Drug Advertising Expense Reporting.

This section is new; therefore, strike-throughs and underscoring have been omitted.
This Web site is maintained by the West Virginia Legislature's Office of Reference & Information.  |  Terms of Use  |   Email WebmasterWebmaster   |   © 2024 West Virginia Legislature **


X

Print On Demand

Name:
Email:
Phone:

Print